Fortrea Holdings FTRE
NASDAQ FTRE
$18.16 -0.46 (-2.47%)
As of: Sep 4, 2026 · 1:30 PM EDT

Fortrea Holdings (FTRE) Interest & Investment Income (2023 - 2026)

Analysis

Fortrea Holdings (FTRE) Interest & Investment Income (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 35.58 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 5.13 Mn
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 10.98 Mn
10 Fortrea Holdings 1.72 Bn 1.55 Bn 139.20 Mn -19.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.30 Mn
Mar 31, 2026 -19.10 Mn
Dec 31, 2025 -23.20 Mn
Sep 30, 2025 -22.60 Mn
Jun 30, 2025 -23.30 Mn
Mar 31, 2025 -22.30 Mn
Dec 31, 2024 -21.90 Mn
Sep 30, 2024 -22.40 Mn
Jun 30, 2024 -45.20 Mn
Mar 31, 2024 -34.30 Mn
Dec 31, 2023 -34.50 Mn
Sep 30, 2023 -34.60 Mn
Jun 30, 2023 -700,000.00